Literature DB >> 10559213

Sympathetic potentiation of cyclic ADP-ribose formation in rat cardiac myocytes.

H Higashida1, A Egorova, C Higashida, Z G Zhong, S Yokoyama, M Noda, J S Zhang.   

Abstract

We examined the role of cyclic ADP-ribose (cADP-ribose) as a second messenger downstream of adrenergic receptors in the heart after excitation of sympathetic neurons. To address this question, ADP-ribosyl cyclase activity was measured as the rate of [(3)H]cADP-ribose formation from [(3)H]NAD(+) in a crude membrane fraction of rat ventricular myocytes. Isoproterenol at 1 microM increased ADP-ribosyl cyclase activity by 1.7-fold in ventricular muscle; this increase was inhibited by propranolol. The stimulatory effect on the cyclase was mimicked by 10 nM GTP and 10 microM guanosine 5'-3-O-(thio)triphosphate, whereas 10 microM GTP inhibited the cyclase. Cholera toxin blocked the activation of the cyclase by isoproterenol and GTP. The above effects of isoproterenol and GTP in ventricular membranes were confirmed by cyclic GDP-ribose formation fluorometrically. These results demonstrate the existence of a signal pathway from beta-adrenergic receptors to membrane-bound ADP-ribosyl cyclase via G protein in the ventricular muscle cells and suggest that increased cADP-ribose synthesis is involved in up-regulation of cardiac function by sympathetic stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559213     DOI: 10.1074/jbc.274.47.33348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Generation of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate by CD38 for Ca2+ signaling in interleukin-8-treated lymphokine-activated killer cells.

Authors:  So-Young Rah; Mazhar Mushtaq; Tae-Sik Nam; Suhn Hee Kim; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

3.  ADP-ribosyl cyclases generate two unusual adenine homodinucleotides with cytotoxic activity on mammalian cells.

Authors:  Giovanna Basile; Orazio Taglialatela-Scafati; Gianluca Damonte; Andrea Armirotti; Santina Bruzzone; Lucrezia Guida; Luisa Franco; Cesare Usai; Ernesto Fattorusso; Antonio De Flora; Elena Zocchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

4.  Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Authors:  Ingrid Bacher; Andreas Zidar; Martin Kratzel; Martin Hohenegger
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 5.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor.

Authors:  Martin Hohenegger; Josef Suko; Regina Gscheidlinger; Helmut Drobny; Andreas Zidar
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

7.  Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

8.  Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.

Authors:  Pin-Lan Li; Yang Zhang; Justine M Abais; Joseph K Ritter; Fan Zhang
Journal:  Messenger (Los Angel)       Date:  2013-06-01

9.  Two intracellular pathways mediate metabotropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons.

Authors:  Hitoshi Morikawa; Kamran Khodakhah; John T Williams
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.